Pharma News - Chemdiv

Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits

While there’s no doubt about the success of the Pfizer and BioNTech COVID-19 vaccines, with that kind of success comes significant scrutiny and legal action. ...

Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits

In its second quarter financial report this year, Teva Pharmaceuticals announced that it had arrived at an almost $5-billion settlement for thousands of pending opioid liability lawsuits. ...

As Omicron Mutates, Researchers Compare Efficacy of Therapeutic Antibodies and Antivirals

As the BA.4 and BA.5 Omicron subvariants become the dominant strains of COVID-19 around the world, researchers are evaluating just how well vaccines and therapies work against these extremely infec...

FDA’s Oncologic Drugs Advisory Committee to Discuss Three NDA Cancer Drugs

The FDA has scheduled a meeting of its Oncologic Drugs Advisory Committee on Sept. 22 and 23 to discuss New Drug Applications (NDA) for three cancer drugs.

Researchers discover gene that promotes muscle strength during exercise

Researchers have identified a gene that promotes muscle strength when switched on by physical activity, unlocking the potential for the development of therapeutic treatments to mimic some of the be...

Years of Alzheimer's research were based on a key finding. Now an investigation alleges it was faked, and the work may have been wasted.

Results of a seminal 2006 Alzheimer's paper appear fabricated, an investigation said.

Pfizer to Spend $470 Million in Expansion of Vaccine Research Facilities

Pfizer is planning a $470 million expansion of its vaccine research facility in Pearl River, N.Y. which played a leading role on the co-development of the company’s COVID-19 vaccine with BioNTech...

Takeda’s Hyqvia Shows Promise for CIDP in Phase 3 Study

Takeda’s investigational drug Hyqvia (immune globulin with recombinant human hyaluronidase) showed promise in a late-stage clinical trial for patients with chronic inflammatory demyelinating poly...

NICE Recommends Rhythm’s Imcivree for Obesity and Hunger

The UK’s National Institute of Health and Care Excellence (NICE) has recommended Rhythm Pharmaceuticals’ Imcivree (setmelanotide) for National Health Service (NHS) use in treating obesity linke...

A more concise way to synthesize tetrodotoxin

A small international team of researchers has developed a way to synthesize tetrodotoxin (TTX) using far fewer steps than prior methods.

Biogen Agrees to Pay $900 Million in Settlement Over Multiple Sclerosis Drugs

Biogen has agreed in principle to pay $900 million to settle a whistleblower lawsuit over alleged kickbacks to physicians before the case goes to a jury trial in Boston next week. ...

EU drug regulator recommends clearing vaccine for monkeypox

The European Medicines Agency said Friday that the smallpox vaccine made by Bavarian Nordic should also be authorized against monkeypox, as the outbreak of the once-rare disease continues to sicken...